An excellent case study exemplifying the benefits of polymer conjugation is pegfilgrastim, a PEGylated human granulocyte colony-stimulating factor (G-CSF) approved in 2002 for the prophylactic treatment of neutropenia during chemotherapy. The gene discussed is CSF3; the disease is Decreased total neutrophil count.